Sri Trang Gloves (Thailand) PCL (BKK:STGT)

Verve Therapeutics Ratios and Metrics

Market cap in millions THB. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	20,200	28,222	19,197	28,652	86,614	108,587
Market Cap Growth	-18.39%	47.02%	-33.00%	-66.92%	-20.24%	-
Enterprise Value	21,388	29,901	16,846	22,930	69,970	96,480
Last Close Price	7.05	9.19	5.91	8.60	24.55	26.43
PE Ratio	15.72	28.36	125.72	17.34	3.65	7.54
Forward PE	13.53	19.30	12.20	13.69	5.95	6.23
PS Ratio	0.79	1.13	0.98	1.23	1.82	3.55
PB Ratio	0.52	0.73	0.52	0.78	2.27	3.37
P/TBV Ratio	0.53	0.74	0.53	0.79	2.29	3.40
P/FCF Ratio	-	-	31.58	-	6.45	9.56
P/OCF Ratio	-	23.11	11.40	7.01	3.60	8.08
PEG Ratio	-	0.03	0.03	0.03	0.03	-
EV/Sales Ratio	0.84	1.20	0.86	0.98	1.47	3.16
EV/EBITDA Ratio	5.75	9.71	9.83	7.21	2.64	5.67
EV/EBIT Ratio	13.59	27.28	157.53	12.76	2.76	6.05
EV/FCF Ratio	33.75	-	27.71	-	5.21	8.49
Debt / Equity Ratio	0.17	0.19	0.19	0.24	0.22	0.21
Debt / EBITDA Ratio	1.73	2.33	4.00	2.76	0.32	0.39
Debt / FCF Ratio	10.12	-	11.57	-	0.64	0.59
Asset Turnover	0.53	0.52	0.41	0.47	1.00	1.06
Inventory Turnover	5.13	5.31	4.86	4.68	4.80	5.60
Quick Ratio	1.39	1.29	2.73	3.77	4.34	4.89
Current Ratio	2.24	1.94	3.63	4.62	5.23	5.50
Return on Equity (ROE)	3.30%	2.64%	0.41%	4.40%	67.27%	78.56%
Return on Assets (ROA)	2.05%	1.44%	0.14%	2.25%	33.14%	34.68%
Return on Capital (ROIC)	2.18%	1.53%	0.15%	2.43%	36.95%	39.52%
Return on Capital Employed (ROCE)	3.80%	2.60%	0.30%	4.10%	55.50%	41.90%
Earnings Yield	6.30%	3.53%	0.80%	5.77%	27.37%	13.26%
FCF Yield	3.14%	-0.12%	3.17%	-10.44%	15.50%	10.46%
Dividend Yield	7.09%	5.44%	8.47%	8.72%	18.94%	9.93%
Payout Ratio	112.55%	143.92%	469.12%	199.36%	72.37%	12.40%
Buyback Yield / Dilution	3.37%	-	-0.02%	-0.12%	-17.91%	-59.08%
Total Shareholder Return	10.67%	5.44%	8.44%	8.60%	1.03%	-49.15%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.